Titre : |
Contribution à l’amélioration de l’activité biologique des inhibiteurs de la dipeptidyl-peptidase 4 dans le diabète de type 2 par simulation informatique. |
Type de document : |
texte imprimé |
Auteurs : |
El-Hassen Mokrani, Auteur ; Abdellatif Bensegueni, Directeur de thèse |
Editeur : |
Constantine : Université Mentouri Constantine |
Année de publication : |
2012 |
Importance : |
102 f. |
Format : |
31 cm. |
Note générale : |
2 copies imprimées disponibles |
Langues : |
Français (fre) |
Catégories : |
Français - Anglais Biologie
|
Tags : |
Biochimie:Technologie des explorations biochimiques AutoDock Dipeptidyl-peptidase 4 Docking moléculaire Inhibiteur Energie d’interaction Binding energy Molecular docking inhibitor أنزيم DDP4 طاقة الارتباط مثبط |
Index. décimale : |
570 Sciences de la vie. Biologie |
Résumé : |
Type 2 diabetes mellitus (T2DM) is a severe and increasingly prevalent disease that is considered as a major global public health. It engenders about four millions death in the world.In our research, we focus on type 2 diabetes treatments based on inhibition of Dipeptidyl-peptidase 4 (DPP4). This enzyme cleaves the incritin hormones which help organism to regulate glycemia only in the case of hyperglycemia. The molecular modeling program: AutoDock, is used to develop in silico new potent DPP4 inhibitors. By poly-substitution of the inhibitor 356 in complex with DPP4 (PDB accession code:2RGU), the binding energy was increased from -11.13Kcal/Mol to -15.13 Kcal/Mol, by the introduction of NH2 on carbon 26, methyl on carbon 34 and finally, the replacement of methyl 14 by CH2CH2NH3+. The application of Lipinski rule informs us in a positive way about ADME/Tox properties of this compound that is considered as a potent DPP4 inhibitor. |
Note de contenu : |
Annexes. |
Diplôme : |
Magistère |
En ligne : |
../theses/biologie/MOK6107.pdf |
Format de la ressource électronique : |
pdf |
Permalink : |
index.php?lvl=notice_display&id=6032 |
Contribution à l’amélioration de l’activité biologique des inhibiteurs de la dipeptidyl-peptidase 4 dans le diabète de type 2 par simulation informatique. [texte imprimé] / El-Hassen Mokrani, Auteur ; Abdellatif Bensegueni, Directeur de thèse . - Constantine : Université Mentouri Constantine, 2012 . - 102 f. ; 31 cm. 2 copies imprimées disponibles Langues : Français ( fre)
Catégories : |
Français - Anglais Biologie
|
Tags : |
Biochimie:Technologie des explorations biochimiques AutoDock Dipeptidyl-peptidase 4 Docking moléculaire Inhibiteur Energie d’interaction Binding energy Molecular docking inhibitor أنزيم DDP4 طاقة الارتباط مثبط |
Index. décimale : |
570 Sciences de la vie. Biologie |
Résumé : |
Type 2 diabetes mellitus (T2DM) is a severe and increasingly prevalent disease that is considered as a major global public health. It engenders about four millions death in the world.In our research, we focus on type 2 diabetes treatments based on inhibition of Dipeptidyl-peptidase 4 (DPP4). This enzyme cleaves the incritin hormones which help organism to regulate glycemia only in the case of hyperglycemia. The molecular modeling program: AutoDock, is used to develop in silico new potent DPP4 inhibitors. By poly-substitution of the inhibitor 356 in complex with DPP4 (PDB accession code:2RGU), the binding energy was increased from -11.13Kcal/Mol to -15.13 Kcal/Mol, by the introduction of NH2 on carbon 26, methyl on carbon 34 and finally, the replacement of methyl 14 by CH2CH2NH3+. The application of Lipinski rule informs us in a positive way about ADME/Tox properties of this compound that is considered as a potent DPP4 inhibitor. |
Note de contenu : |
Annexes. |
Diplôme : |
Magistère |
En ligne : |
../theses/biologie/MOK6107.pdf |
Format de la ressource électronique : |
pdf |
Permalink : |
index.php?lvl=notice_display&id=6032 |
|